Silași, A.D.A.; Sievert, A.C.; Danciu, P.; Lefter, A.V.; Afrasanie, V.A.; Sur, D.
Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness. Diagnostics 2024, 14, 654.
https://doi.org/10.3390/diagnostics14060654
AMA Style
Silași ADA, Sievert AC, Danciu P, Lefter AV, Afrasanie VA, Sur D.
Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness. Diagnostics. 2024; 14(6):654.
https://doi.org/10.3390/diagnostics14060654
Chicago/Turabian Style
Silași, Alexandru Dorin Adrian, Anna Carolin Sievert, Paul Danciu, Andrei Vlad Lefter, Vlad Adrian Afrasanie, and Daniel Sur.
2024. "Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness" Diagnostics 14, no. 6: 654.
https://doi.org/10.3390/diagnostics14060654
APA Style
Silași, A. D. A., Sievert, A. C., Danciu, P., Lefter, A. V., Afrasanie, V. A., & Sur, D.
(2024). Combined Anti-PD-1 and Anti-CTLA-4 Treatment in Stage IV Melanoma Patients: A Bicentric Analysis of Real-World Data and a Modern Treatment Scenario Proving Lactate Dehydrogenase’s Usefulness. Diagnostics, 14(6), 654.
https://doi.org/10.3390/diagnostics14060654
